• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

锌指蛋白转录抑制因子解析亨廷顿病中的神经元和星形胶质细胞的作用。

Neuronal and astrocytic contributions to Huntington's disease dissected with zinc finger protein transcriptional repressors.

机构信息

Department of Physiology, University of California Los Angeles, Los Angeles, CA 90095-1751, USA.

Department of Biological Chemistry, University of California Los Angeles, Los Angeles, CA 90095-1751, USA.

出版信息

Cell Rep. 2023 Jan 31;42(1):111953. doi: 10.1016/j.celrep.2022.111953. Epub 2023 Jan 7.

DOI:10.1016/j.celrep.2022.111953
PMID:36640336
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9898160/
Abstract

Huntington's disease (HD) is caused by expanded CAG repeats in the huntingtin gene (HTT) resulting in expression of mutant HTT proteins (mHTT) with extended polyglutamine tracts, including in striatal neurons and astrocytes. It is unknown whether pathophysiology in vivo can be attenuated by lowering mHTT in either cell type throughout the brain, and the relative contributions of neurons and astrocytes to HD remain undefined. We use zinc finger protein (ZFP) transcriptional repressors to cell-selectively lower mHTT in vivo. Astrocytes display loss of essential functions such as cholesterol metabolism that are partly driven by greater neuronal dysfunctions, which encompass neuromodulation, synaptic, and intracellular signaling pathways. Using transcriptomics, proteomics, electrophysiology, and behavior, we dissect neuronal and astrocytic contributions to HD pathophysiology. Remarkably, brain-wide delivery of neuronal ZFPs results in strong mHTT lowering, rescue of HD-associated behavioral and molecular phenotypes, and significant extension of lifespan, findings that support translational development.

摘要

亨廷顿病(HD)是由亨廷顿基因(HTT)中的 CAG 重复扩展引起的,导致突变 HTT 蛋白(mHTT)的表达,其具有延伸的多聚谷氨酰胺片段,包括纹状体神经元和星形胶质细胞。目前尚不清楚通过降低整个大脑中这两种细胞类型中的 mHTT 是否可以减轻体内的病理生理学,神经元和星形胶质细胞对 HD 的相对贡献仍未确定。我们使用锌指蛋白(ZFP)转录抑制剂在体内选择性地降低 mHTT。星形胶质细胞表现出丧失胆固醇代谢等必需功能,这些功能部分是由更大的神经元功能障碍驱动的,其中包括神经调节、突触和细胞内信号通路。通过转录组学、蛋白质组学、电生理学和行为学,我们剖析了神经元和星形胶质细胞对 HD 病理生理学的贡献。值得注意的是,脑内广泛递送神经元 ZFPs 可显著降低 mHTT,挽救与 HD 相关的行为和分子表型,并显著延长寿命,这些发现支持了转化发展。

相似文献

1
Neuronal and astrocytic contributions to Huntington's disease dissected with zinc finger protein transcriptional repressors.锌指蛋白转录抑制因子解析亨廷顿病中的神经元和星形胶质细胞的作用。
Cell Rep. 2023 Jan 31;42(1):111953. doi: 10.1016/j.celrep.2022.111953. Epub 2023 Jan 7.
2
Astrocyte molecular signatures in Huntington's disease.亨廷顿病中的星形胶质细胞分子特征。
Sci Transl Med. 2019 Oct 16;11(514). doi: 10.1126/scitranslmed.aaw8546.
3
Astrocyte transduction is required for rescue of behavioral phenotypes in the YAC128 mouse model with AAV-RNAi mediated HTT lowering therapeutics.星形胶质细胞转导是用 AAV-RNAi 介导的 HTT 降低治疗方法拯救 YAC128 小鼠模型行为表型所必需的。
Neurobiol Dis. 2019 Sep;129:29-37. doi: 10.1016/j.nbd.2019.04.015. Epub 2019 Apr 28.
4
Astrocytic contributions to Huntington's disease pathophysiology.星形胶质细胞对亨廷顿病病理生理学的贡献。
Ann N Y Acad Sci. 2023 Apr;1522(1):42-59. doi: 10.1111/nyas.14977. Epub 2023 Mar 2.
5
Mutant Huntingtin Inhibits αB-Crystallin Expression and Impairs Exosome Secretion from Astrocytes.突变型亨廷顿蛋白抑制αB-晶状体蛋白表达并损害星形胶质细胞的外泌体分泌。
J Neurosci. 2017 Sep 27;37(39):9550-9563. doi: 10.1523/JNEUROSCI.1418-17.2017. Epub 2017 Sep 11.
6
Downregulation of glial genes involved in synaptic function mitigates Huntington's disease pathogenesis.下调与突触功能相关的神经胶质基因可减轻亨廷顿病的发病机制。
Elife. 2021 Apr 19;10:e64564. doi: 10.7554/eLife.64564.
7
Mutant huntingtin reduction in astrocytes slows disease progression in the BACHD conditional Huntington's disease mouse model.星形胶质细胞中突变亨廷顿蛋白的减少减缓了 BACHD 条件性亨廷顿病小鼠模型的疾病进展。
Hum Mol Genet. 2019 Feb 1;28(3):487-500. doi: 10.1093/hmg/ddy363.
8
Astrocytes are key but indirect contributors to the development of the symptomatology and pathophysiology of Huntington's disease.星形胶质细胞是亨廷顿舞蹈症症状学和病理生理学发展的关键但间接促成因素。
Glia. 2016 Nov;64(11):1841-56. doi: 10.1002/glia.23022. Epub 2016 Jul 21.
9
Amelioration of Huntington's disease phenotype in astrocytes derived from iPSC-derived neural progenitor cells of Huntington's disease monkeys.亨廷顿病猴诱导多能干细胞源性神经祖细胞衍生的星形胶质细胞改善亨廷顿病表型。
PLoS One. 2019 Mar 21;14(3):e0214156. doi: 10.1371/journal.pone.0214156. eCollection 2019.
10
Loss of huntingtin function slows synaptic vesicle endocytosis in striatal neurons from the htt mouse model of Huntington's disease.亨廷顿病 htt 小鼠模型纹状体神经元中 huntingtin 功能丧失会减缓突触囊泡内吞作用。
Neurobiol Dis. 2020 Feb;134:104637. doi: 10.1016/j.nbd.2019.104637. Epub 2019 Oct 12.

引用本文的文献

1
The cell-surface shared proteome of astrocytes and neurons and the molecular foundations of their multicellular interactions.星形胶质细胞和神经元的细胞表面共享蛋白质组及其多细胞相互作用的分子基础。
Neuron. 2025 Jun 5. doi: 10.1016/j.neuron.2025.05.019.
2
Distinct molecular patterns in R6/2 HD mouse brain: Insights from spatiotemporal transcriptomics.R6/2转基因亨廷顿舞蹈症小鼠大脑中的独特分子模式:时空转录组学的见解
Neuron. 2025 Jun 6. doi: 10.1016/j.neuron.2025.05.014.
3
Astrocyte morphogenesis requires self-recognition.星形胶质细胞形态发生需要自我识别。

本文引用的文献

1
Altered Cholesterol Homeostasis in Huntington's Disease.亨廷顿舞蹈病中胆固醇稳态的改变
Front Aging Neurosci. 2022 Apr 19;14:797220. doi: 10.3389/fnagi.2022.797220. eCollection 2022.
2
An orally available, brain penetrant, small molecule lowers huntingtin levels by enhancing pseudoexon inclusion.一种可口服、可穿透血脑屏障的小分子通过增强假外显子的包含来降低亨廷顿蛋白水平。
Nat Commun. 2022 Mar 3;13(1):1150. doi: 10.1038/s41467-022-28653-6.
3
Small molecule splicing modifiers with systemic HTT-lowering activity.具有系统降低 HTT 活性的小分子剪接修饰物。
Nature. 2025 May 28. doi: 10.1038/s41586-025-09013-y.
4
Homeostasis and metabolism of iron and other metal ions in neurodegenerative diseases.神经退行性疾病中铁及其他金属离子的稳态与代谢
Signal Transduct Target Ther. 2025 Feb 3;10(1):31. doi: 10.1038/s41392-024-02071-0.
5
Long somatic DNA-repeat expansion drives neurodegeneration in Huntington's disease.长链体细胞DNA重复序列扩增导致亨廷顿舞蹈症中的神经退行性变。
Cell. 2025 Feb 6;188(3):623-639.e19. doi: 10.1016/j.cell.2024.11.038. Epub 2025 Jan 16.
6
Therapeutic approaches targeting aging and cellular senescence in Huntington's disease.针对亨廷顿病的衰老和细胞衰老的治疗方法。
CNS Neurosci Ther. 2024 Oct;30(10):e70053. doi: 10.1111/cns.70053.
7
Multi-omic analysis of Huntington's disease reveals a compensatory astrocyte state.多组学分析亨廷顿病揭示了代偿性星形胶质细胞状态。
Nat Commun. 2024 Aug 8;15(1):6742. doi: 10.1038/s41467-024-50626-0.
8
Immunological aspects of central neurodegeneration.中枢神经变性的免疫学方面
Cell Discov. 2024 Apr 9;10(1):41. doi: 10.1038/s41421-024-00666-z.
9
Astrocytes in selective vulnerability to neurodegenerative disease.选择性易患神经退行性疾病的星形胶质细胞。
Trends Neurosci. 2024 Apr;47(4):289-302. doi: 10.1016/j.tins.2024.02.008. Epub 2024 Mar 22.
10
A concerted neuron-astrocyte program declines in ageing and schizophrenia.神经元-星形胶质细胞协同程序在衰老和精神分裂症中下降。
Nature. 2024 Mar;627(8004):604-611. doi: 10.1038/s41586-024-07109-5. Epub 2024 Mar 6.
Nat Commun. 2021 Dec 15;12(1):7299. doi: 10.1038/s41467-021-27157-z.
4
Huntington's disease mouse models: unraveling the pathology caused by CAG repeat expansion.亨廷顿舞蹈症小鼠模型:揭示由CAG重复序列扩增引起的病理学机制
Fac Rev. 2021 Oct 21;10:77. doi: 10.12703/r/10-77. eCollection 2021.
5
Synaptic Vesicle Glycoprotein 2A Is Affected in the Central Nervous System of Mice with Huntington Disease and in the Brain of a Human with Huntington Disease Postmortem.突触囊泡糖蛋白 2A 在亨廷顿病小鼠的中枢神经系统和亨廷顿病人类死后大脑中受到影响。
J Nucl Med. 2022 Jun;63(6):942-947. doi: 10.2967/jnumed.121.262709. Epub 2021 Sep 16.
6
Cell-intrinsic glial pathology is conserved across human and murine models of Huntington's disease.细胞内神经胶质病理学在亨廷顿病的人类和小鼠模型中是保守的。
Cell Rep. 2021 Jul 6;36(1):109308. doi: 10.1016/j.celrep.2021.109308.
7
Use of high-content imaging to quantify transduction of AAV-PHP viruses in the brain following systemic delivery.利用高内涵成像技术对全身给药后大脑中AAV-PHP病毒的转导进行定量分析。
Brain Commun. 2021 May 17;3(2):fcab105. doi: 10.1093/braincomms/fcab105. eCollection 2021.
8
SREBP2 gene therapy targeting striatal astrocytes ameliorates Huntington's disease phenotypes.靶向纹状体星形胶质细胞的 SREBP2 基因治疗改善亨廷顿病表型。
Brain. 2021 Nov 29;144(10):3175-3190. doi: 10.1093/brain/awab186.
9
Widespread and sustained target engagement in Huntington's disease minipigs upon intrastriatal microRNA-based gene therapy.纹状体内基于 microRNA 的基因治疗可广泛且持续地靶向亨廷顿病小型猪。
Sci Transl Med. 2021 Apr 7;13(588). doi: 10.1126/scitranslmed.abb8920.
10
Insights into kinetics, release, and behavioral effects of brain-targeted hybrid nanoparticles for cholesterol delivery in Huntington's disease.用于亨廷顿病中胆固醇递送的脑靶向杂化纳米粒子的动力学、释放和行为效应的深入了解。
J Control Release. 2021 Feb 10;330:587-598. doi: 10.1016/j.jconrel.2020.12.051. Epub 2021 Jan 5.